DEGENERATIVE OSTEOARTHRITIS

Ankle osteoarthritis is a condition that causes pain and stiffness in the ankle joint. Traditional treatments like joint fusion can limit mobility. An alternative procedure called ankle distraction arthroplasty has been gaining some traction, but how well does it hold up in the long term? 

A recent study by Greenfield et al. (2019) investigated this very question. They conducted a survival analysis of ankle distraction arthroplasty for ankle osteoarthritis. Their findings suggest that this procedure may be a viable option for some patients. 

Key takeaways from the study: 

  • Ankle distraction arthroplasty showed promising results, with an 84% survival rate at 5 years. This is better than some previously reported outcomes. 
  • The study also identified factors that can influence the success of the procedure. Avascular necrosis of the talus (bone death) was associated with a lower survival rate. Additionally, sex may play a role, with the study suggesting potential gender differences in long-term outcomes. 

What this means for patients: 

Ankle distraction arthroplasty offers a potential option for preserving joint mobility in patients with ankle osteoarthritis. This study provides valuable data for surgeons and patients to consider when making treatment decisions. 

Important to note: 

  • This was a retrospective study, meaning researchers analyzed past data. More robust research designs are needed to confirm these findings. 
  • The study involved a relatively small group of patients. Larger studies are necessary to draw more definitive conclusions. 

Overall, this research suggests that ankle distraction arthroplasty may be a valuable tool for treating ankle osteoarthritis. However, more research is needed to solidify its place as a standard treatment option. 

ReferenceGreenfield, S., Matta, K. M., McCoy, T. H., Rozbruch, S. R., & Fragomen, A. (2019). Ankle distraction arthroplasty for ankle osteoarthritis: a survival analysis. Strategies in trauma and limb reconstruction, 14(2), 65. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376580/#:~:text=In%20a%20significantly%20larger%20series,and%2037%25%20within%205%20years

Disclaimer:

This blog is for informational purposes only and should not be considered as medical advice. Always consult with a qualified healthcare professional to discuss your individual treatment options.
 

Always warm-up before jogging or injury occurs…

Image Credits: Harvard Health – Harvard University

What is Degenerative Osteoarthritis? 

Osteoarthritis is an acute or chronic inflammation of a joint. Arthritis symptoms are variable but often include pain and changes to the joint. Up to 10%–15% of all adults aged over 60 had some degree of symptomatic OA, with prevalence higher among females than males [1].

As a partially autoimmune condition, one of the best ways to control Osteoarthritis is via the appropriate diet and lifestyle changes. Statistically Osteoarthritis(OA) is one of the most commonly treated orthopaedic conditions. Many older adults suffer from this condition, due to the fact that joint components like cartilage, take a long time to heal. With advances in medicine, OA is now being combatted with conditions such as stem cell treatment. 

In the progression of OA, patients often exhibit symptoms such as the capsule-bursa tissue inflammation, synovial fluid modifications, cartilage breakdown and erosions, osteochondral inflammatory damage leading to bone erosion and distortion.[1]

One of the underlying reasons that medical treatments are being developed for conditions like OA is because the underlying mechanisms of propagation of the disease is identified. During the initial phases of the inflammatory-immunologic process, researchers have identified the pathways that contribute to this state. There are additional disease elements such as synoviocytes (A and B), chrondrocytes, extracellular matrix, local immune-inflammatory mediators and proteases. How these all interact in the generation process is still being investigated by medical researchers. With the advent of stem cell therapy however, mesenchymal stem cells (MSCs) have found immense use in the healing of OA. The MSCs counter the inflammatory-immunologic processes and facilitate healing. 

How do Stem Cells or Growth Factors Regenerate the Body? 

The stem cell has long been identified as the regenerative life force in our bodies. With their ability to divide and duplicate, as well as generate new and different stem cells that are relevant to a healing site, it is possible to regenerate cartilage cells and even bone cells. This is great news for the arthritic foot. Over time, the joint can wear away, and with the ability to rebuild it naturally, it will save the individual time from having to go through processes like harvesting. 

How are Stem Cells Administered? 

Stem cells are administered either surgically, or via injection into the arthritic joint. Much like the image above, your orthopaedic surgeon will utilize medical imaging in order to identify where on the body, the stem cells are to be administered. Depending on the severity of the injury, either of the two options will be applied. When the stem cells are being administered, your orthopaedic surgeon will more than likely utilize mesenchymal stem cells that have been harvested from the individual’s body. 

Studies have identified that joint-resident MSC’s are integral to the facilitation of joint regeneration stability, and also regulate cell turn over and tissue repair. A regenerative microenvironment is the outcome of introduction of MSCs into an arthritic joint. The reversal of OA is now possible with these newly understood mechanisms. 

Cartilage Degeneration 

With an understanding of OA biological processes that trigger OA, the primary aim now is to identify the means to minimise cartilage degeneration. Resident joint MSCs work to modulate local inflammatory and immunologic responses. Thus far, MSCs seem promising for both early stage OA all the way to more advanced joint degeneration. 

RESTORATIVE SITES IN OA

The knee joint forms a joint capsule where all the bones meet in the hinge mechanism. Within the joint is a fibrous membrane that is composed of connective fibrous tissue. The nervous system permeates this area introducing feeling, while muscles and tendons facilitate the motion and flexibility of the joint. The synovial membrane in the joint, is the point where the special mesenchymal tissue resides. This is the point of regeneration. As a regenerative site, there is a dense net of capillary vessels that provide the nutrients that are distributed via processes such as diffusion. All joints have a fibrous membrane structure that varies in thickness in different parts of the body. For this reason, it is possible to transfer some of the MSCs from the fatty parts of the body into sites that need to be regenerated. They can’t always be generated in situ, but they can be transferred from a pre-existing site.

Within the synovial membrane complex is the important function of generating synovial fluid, as well as the sustenance of the Extracellular Matrix that is a cell host. Synovial fluid is a key element in the health of the cartilage. It supports the superficial and middle zones of the cartilage, and provides them with nutrients. 

The General Properties of MSCs 

MSCs are members of the stem cell family. The innate ability of all stem cells is to generate mesenchymal lineages such as fibroblasts, chondroblasts, adipocytes, muscle-cells, osteoblasts and other mesenchymal lineages [1]. This ability of the stem cell to forge differing cell groups is what facilitates the in vivo proliferation and differentiation in the regenerative microenvironment that is the joint. Their mechanisms of action include autocrine and paracrine effects. Medical research is still delving into the various mechanisms of action of the MSC cells. They have various interactions with critical receptors in the joint capsule. One thing that activates the already resident MSCs in the joint is presence of tissue injury and inflammation. The regenerative mechanisms are activated once these conditions are induced. Local immune modulation and trophic effects are two of the primary functions of the MSCs. MSCs as a heterogenous stem cell population that generate the relevant cells needed for healing in a tissue-specific microenvironment. They adapt to their environment. 

MSC Exosome Research 

In the past decade, research in MSC has resulted in several experimental models that have ultimately led to clinical applications. Since the MSC’s show great promise in promotion of healing and tissue regeneration there is a lot of interest in their utilization. What is the current concern of researchers is to ensure that the survival rate of MSCS during and after transplants is understood. Survival rate verification is currently to be determined, and future research is still to understand the full mechanisms of action once the transplanted cells are placed in the host tissue. Unlike drugs whose concentrations and paths are traceable, there is still a lot to be learned from the Stem Cell research. Sometimes in the research process, when MSCs were intended for proliferation they would act in an immune-regenerative function instead. This inability to specify the mechanism is what is limiting the use of the MSCs  and also the progress of usage in therapies. The root of this condition is linked to a process known as paracrine action. Studies have linked this outcome to the secretion of exosomes. These membrane-enclosed vesicles favor regeneration. Knowing how to adjust the lever to the right specificity will be the key to a successful future. 

Reference Article: 

  1. ScienceDirect: https://www.sciencedirect.com/science/article/pii/S2352320420300651

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Dr. Gordon Slater

Dr. Slater is one of the first foot and ankle surgeons in Australia to adopt minimally invasive surgical techniques. He routinely uses MIS to treat a range of conditions, including bunions.

Leave a comment

Dr Gordon Slater is a highly-skilled surgeon specialising in foot and ankle conditions and sports injuries. Dr Slater is one of the first foot and ankle surgeons in Australia to adopt minimally invasive surgical techniques. He routinely uses MIS to treat a range of conditions, including bunions. MIS  has many advantages including shorter operating times, reduced post-operative pain, reduced risk of infection, minimal scarring and better cosmetic outcomes.

Copyright © 2022 orthopaedic-surgeon.com.au